Skip to main content

Souza Marcio

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Souza Marcio as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

PRAX Praxis Precision Medicines, Inc.

Chief Executive Officer5 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 27, 2023 (view filing)Jun 27Same daySouza MarcioChief Executive OfficerPPurchase+10.0K$1.06+$10.6K+28.6%45.0K after
Mar 27, 2023 (view filing)Mar 234 daysSouza MarcioChief Executive OfficerPPurchase+35.0K$0.86+$30.1K+18.3%226.3K after
Mar 27, 2023 (view filing)Mar 234 daysSouza MarcioChief Executive OfficerPPurchase+35.0K$0.86+$30.1KNew position35.0K after
Jun 9, 2022 (view filing)Jun 81 daySouza MarcioChief Executive OfficerPPurchase+27.0K$1.85+$50.0K+16.6%189.2K after
Aug 19, 2021 (view filing)Aug 181 daySouza MarcioChief Executive OfficerPPurchase+9.54K$15.79+$150.7K+12.4%86.8K after

SYRE Spyre Therapeutics, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 25, 2022 (view filing)Aug 25Same daySouza MarcioDirectorPPurchase+90.0K$0.56+$50.4KNew position90.0K after